IX BIOPHARMA LTD. 200405621W

1 Kim Seng Promenade, #14-01 Great World City East Tower, Singapore, 237994

72

198

Announcements

IX BIOPHARMA LTD. Administrator
Sep 15 2025 1.01AM
Podcast Shareholders

BREAKING:


iX Biopharma LTD achieved robust financial performance with significant revenue and gross profit growth, alongside reduced adjusted EBITDA losses. The Group is strategically scaling its wellness business and accelerating its pharmaceutical pipeline's market entry, leveraging unique sublingual technologies.

 

• Discover how proprietary sublingual technologies are revolutionising drug delivery and market potential

 

• Explore a key wellness product's strategic expansion into a dynamic longevity market

 

• Learn about the accelerated commercialisation of pharmaceutical assets through targeted partnerships


LISTEN TO THE PODCAST BELOW:



IX BIOPHARMA LTD. Administrator Four
Sep 26 2023 10.34AM
ANNUAL GENERAL MEETING:: VOLUNTARY Shareholders

There will be an AGM on


Event dates:

Meeting Date and Time

13/10/2023 10:00:00

Response Deadline Date

10/10/2023 10:00:00                                


For more information, click here: IX BIOPHARMA LTD. 2023 AGM

Questions from Shareholders